Claybrook Capital’s CME Group CME Stock Holding History

Claybrook Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4	Closed	-$1K	–	184
2018 Q4	$1K	Buy	+4	New	+$739	﹤0.01%	682

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Claybrook Capital's CME Position: Q1 2019 in Review

Claybrook Capital sold out of CME Group (CME) in Q1 2019, closing a stake of 4 shares — an estimated $1K sold.

Claybrook Capital first reported a position in CME in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 1,001 funds tracked by Wall St. Rank hold CME as of Q1 2019.

Claybrook Capital reported no remaining CME Group position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 4 CME Group shares in Q1 2019, an estimated $1K.
Claybrook Capital first reported a position in CME Group in Q4 2018 and held it in 1 quarter.
Claybrook Capital's CME Group position peaked at $1K in Q4 2018.
1,001 funds tracked by Wall St. Rank held CME Group as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.